11 – 20 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
(
- Contribution to journal › Article
- 2006
-
Mark
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group.
(
- Contribution to journal › Article
-
Mark
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
(
- Contribution to journal › Article
- 2005
-
Mark
Frustration över arbetsvillkoren hos svenska verksamhetschefer
(
- Contribution to journal › Article
-
Mark
Nordic Myeloma Study Group, the first 15 years: Scientific collaboration and improvement of patient care
(
- Contribution to journal › Scientific review
-
Mark
Management of patients with polycythaemia vera: results of a survey among Swedish haematologists
(
- Contribution to journal › Article
-
Mark
International Staging System for Multiple Myeloma.
(
- Contribution to journal › Article
- 2004
-
Mark
Physicians as clinical directors: working conditions, psychosocial resources and self-rated health.
(
- Contribution to journal › Article
-
Mark
High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation.
(
- Contribution to journal › Article
-
Mark
Early response predicts thalidomide efficiency in patients with advanced multiple myeloma
(
- Contribution to journal › Article